A Two Cohort, Open Label, Single and Multiple Dose Pharmacokinetic Study of 4mg/Kg and 6mg/Kg Doses of Daptomycin in Healthy Chinese Subjects Living in China.
Phase of Trial: Phase I
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Daptomycin (Primary)
- Indications Bacterial infections; Gram-positive infections; Skin and soft tissue infections
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 19 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Mar 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
- 11 Mar 2009 New trial record